All In MedTech

Device Trial Radar · NCT02701101

Evaluation of the SEM Scanner 200 for the Detection of Early Pressure Ulcers: A Multi-Site Longitudinal Study

Last checked: Nov 20, 2026Latest source record: Oct 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

189

Actual

Start

Apr 2016

Primary completion

Nov 2016

Study completion Mar 2017

Sponsor

Lead sponsor
Bruin Biometrics, LLCNot on our public-company list
Sponsor type
Industry
First posted
Mar 8, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
Double (care provider, outcomes assessor)
Primary purpose
Other
Who can join
All sexes, from 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-site, longitudinal study to evaluate the use of the SEM Scanner as an adjunct to clinical judgment for detection of early pressure ulcers in patients before clinical judgment using signs of pressure ulcers from skin assessments. longitudinal study to evaluate the use of the SEM Scanner as an adjunct to clinical judgment for detection of early pressure ulcers in patients before skin assessments.

Conditions

  • Pressure Ulcers

Interventions

  • Use of SEM200 Scanner dailyDevice

    From enrollment to exit,daily SEM Scanner readings collected on Sacrum and Heels

  • Assessment and treatment of Pressure Ulcers using SOCOther

    Nurse review of Skin risk and skin assessment, notes in chart to assess the frequency to turn patient, use of a specialist bed to prevent or treat early pressure ulcers

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Sensitivity of the SEM Scanner Device (70% or Above) for Detecting Early Pressure Ulcers Before Routine Skin AssessmentsTime frame: A subject was included in the analysis when they had at least one "valid series" within 5 days of visual skin assessment identification of a pressure ulcer (6-21 observation days), or study exit when no pressure ulcer was identified.

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Thomas Jefferson Hospital

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.